中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2008年
3期
238-241
,共4页
马民玉%王承海%冉菊红%阚全程%马君志
馬民玉%王承海%冉菊紅%闞全程%馬君誌
마민옥%왕승해%염국홍%감전정%마군지
布比卡因%药代动力学%麻醉,硬膜外
佈比卡因%藥代動力學%痳醉,硬膜外
포비잡인%약대동역학%마취,경막외
Bupivacaine%Pharmacokinetics%Anesthesia,epidural
目的 探讨患者硬膜外注射不同浓度左旋布比卡因的药代动力学.方法 择期行结肠癌根治术、经腹或腹会阴直肠癌根治术患者20例,ASA Ⅰ或Ⅱ级,年龄35~59岁,随机分为0.75%左旋布比卡因组(Ⅰ组)和0.5%左旋布比卡因组(Ⅱ组),每组10例.麻醉方法为腰段硬膜外阻滞联合全麻.经L1,2硬膜外穿刺成功后,分别经2 min注入0.75%或0.5%左旋布比卡因2 mg/kg.硬膜外注药结束后30 min内记录感觉和运动阻滞效果,记录不良反应发生情况.于注药后即刻、注药后10、20、30、45、60、90、120、210、300、420、540、660和840 min时取中心静脉血3 ml,采用高效液相色谱法测定血浆左旋布比卡因浓度,绘制血浆左旋布比卡因浓度-时间曲线,计算2组药代动力学参数.结果 2组血浆左旋布比卡因浓度-时间曲线均符合二房室开放模型;2组药代动力学参数比较差异均无统计学意义(P>0.05).结论 0.75%和0.5%左旋布比卡因2mg/kg腰段硬膜外阻滞安全性高,血浆药物浓度-时间曲线均符合二房室开放模型,两者药代动力学特性无差异.
目的 探討患者硬膜外註射不同濃度左鏇佈比卡因的藥代動力學.方法 擇期行結腸癌根治術、經腹或腹會陰直腸癌根治術患者20例,ASA Ⅰ或Ⅱ級,年齡35~59歲,隨機分為0.75%左鏇佈比卡因組(Ⅰ組)和0.5%左鏇佈比卡因組(Ⅱ組),每組10例.痳醉方法為腰段硬膜外阻滯聯閤全痳.經L1,2硬膜外穿刺成功後,分彆經2 min註入0.75%或0.5%左鏇佈比卡因2 mg/kg.硬膜外註藥結束後30 min內記錄感覺和運動阻滯效果,記錄不良反應髮生情況.于註藥後即刻、註藥後10、20、30、45、60、90、120、210、300、420、540、660和840 min時取中心靜脈血3 ml,採用高效液相色譜法測定血漿左鏇佈比卡因濃度,繪製血漿左鏇佈比卡因濃度-時間麯線,計算2組藥代動力學參數.結果 2組血漿左鏇佈比卡因濃度-時間麯線均符閤二房室開放模型;2組藥代動力學參數比較差異均無統計學意義(P>0.05).結論 0.75%和0.5%左鏇佈比卡因2mg/kg腰段硬膜外阻滯安全性高,血漿藥物濃度-時間麯線均符閤二房室開放模型,兩者藥代動力學特性無差異.
목적 탐토환자경막외주사불동농도좌선포비잡인적약대동역학.방법 택기행결장암근치술、경복혹복회음직장암근치술환자20례,ASA Ⅰ혹Ⅱ급,년령35~59세,수궤분위0.75%좌선포비잡인조(Ⅰ조)화0.5%좌선포비잡인조(Ⅱ조),매조10례.마취방법위요단경막외조체연합전마.경L1,2경막외천자성공후,분별경2 min주입0.75%혹0.5%좌선포비잡인2 mg/kg.경막외주약결속후30 min내기록감각화운동조체효과,기록불량반응발생정황.우주약후즉각、주약후10、20、30、45、60、90、120、210、300、420、540、660화840 min시취중심정맥혈3 ml,채용고효액상색보법측정혈장좌선포비잡인농도,회제혈장좌선포비잡인농도-시간곡선,계산2조약대동역학삼수.결과 2조혈장좌선포비잡인농도-시간곡선균부합이방실개방모형;2조약대동역학삼수비교차이균무통계학의의(P>0.05).결론 0.75%화0.5%좌선포비잡인2mg/kg요단경막외조체안전성고,혈장약물농도-시간곡선균부합이방실개방모형,량자약대동역학특성무차이.
Objective To investigate the pharmacokinetics of different concentrations of levobupivacaine for lumbar epidural anesthesia.Methods Twenty ASA Ⅰ or Ⅱ patients of both sexes aged 35-59 yr scheduled for elective rectum or colon cancer operation under general anesthesia combined with epidural block were randomly divided into 2 groups(n=10 each):group Ⅰ 0.75% levobupivacaine and group Ⅱ 0.5% levobupivacaine.Epidural block was performed at L1-2 interspace.Group Ⅰ and Ⅱ received epidural 0.75% and 0.5% levobupivacalne 2 mg/kg(containing adrenaline 5 μg/kg)injected slowly over 2 min respectively.Thirty minutes after epidural levobupivacaine,general anesthesia was induced withγ-hydroxybutyrate 60-80 mg/kg,and remifentanil 1-2 μg/kg.Tracheal intubation was facilitated with succinyl choline 1-1.5 mg/kg and the patients were mechanically ventilated.Anesthesia was maintained with inhalation of nitrous oxide and O2(1:1)and continuous blockade were assessed after epidural levobupivacaine.Blood samples were taken from central vein at 0,10,20,30,45,60,90,120,210,300,420,540,660 and 840 min after epidural levobupivacaine for determination of plasma concentration of levobupivacaine by high performance liquid chromatography.Results The plasma concentration-time curves of levobupivacaine were fitted to a two-compartment open model in the two groups and there was no significant difference in the pharmacokinetic profiles between the two groups.The onset time of sensory and motor block was shorter and the duration of the two blocks was longer with 0.75% levobupivacaine as compared with 0.5% levobupivacaine.The incidences of nausea and vomiting and hypotension were low and no severe cardiovascular and neurological side-effects developed.Conclusion The pharmacokinetic parameters do not differ significantly between epidural 0.75% and 0.5% levobupivacaine when the total amount is the same.Epidural anesthesia with either 0.75% or 0.5% levobupivacaine is safe.